Anticoagulation Considerations for Travel to High Altitude

    Research output: Contribution to journalArticle

    Abstract

    DeLoughery, Thomas G. Anticoagulation considerations for travel to high altitude. High Alt Med Biol 16:181-185, 2015.-An increasing percentage of the population are on anticoagulation medicine for clinical reasons ranging from stroke prevention in atrial fibrillation to long term prevention of deep venous thrombosis. In recent years, several new direct oral anticoagulants have entered the market. The key questions that should be kept in mind when approaching a potential traveler on anticoagulation are: 1) why is the patient on anticoagulation? 2) do they need to stay on anticoagulation? 3) what are the choices for their anticoagulation? 4) will there be any drug interactions with medications needed for travel? and 5) how will they monitor their anticoagulation while traveling? Knowing the answers to these questions then can allow for proper counseling and planning for the anticoagulated traveler's trip.

    Original languageEnglish (US)
    Pages (from-to)181-185
    Number of pages5
    JournalHigh Altitude Medicine and Biology
    Volume16
    Issue number3
    DOIs
    StatePublished - Sep 1 2015

    Fingerprint

    Clinical Medicine
    Drug Interactions
    Venous Thrombosis
    Anticoagulants
    Atrial Fibrillation
    Counseling
    Stroke
    Population

    Keywords

    • anticoagulation
    • apixaban
    • dabigatran
    • deep venous thrombosis
    • edoxaban
    • rivaroxaban
    • warfarin

    ASJC Scopus subject areas

    • Medicine(all)
    • Physiology
    • Public Health, Environmental and Occupational Health

    Cite this

    Anticoagulation Considerations for Travel to High Altitude. / Deloughery, Thomas.

    In: High Altitude Medicine and Biology, Vol. 16, No. 3, 01.09.2015, p. 181-185.

    Research output: Contribution to journalArticle

    @article{c41c23d48bcb4f879d4566d8c8ecefd8,
    title = "Anticoagulation Considerations for Travel to High Altitude",
    abstract = "DeLoughery, Thomas G. Anticoagulation considerations for travel to high altitude. High Alt Med Biol 16:181-185, 2015.-An increasing percentage of the population are on anticoagulation medicine for clinical reasons ranging from stroke prevention in atrial fibrillation to long term prevention of deep venous thrombosis. In recent years, several new direct oral anticoagulants have entered the market. The key questions that should be kept in mind when approaching a potential traveler on anticoagulation are: 1) why is the patient on anticoagulation? 2) do they need to stay on anticoagulation? 3) what are the choices for their anticoagulation? 4) will there be any drug interactions with medications needed for travel? and 5) how will they monitor their anticoagulation while traveling? Knowing the answers to these questions then can allow for proper counseling and planning for the anticoagulated traveler's trip.",
    keywords = "anticoagulation, apixaban, dabigatran, deep venous thrombosis, edoxaban, rivaroxaban, warfarin",
    author = "Thomas Deloughery",
    year = "2015",
    month = "9",
    day = "1",
    doi = "10.1089/ham.2015.0058",
    language = "English (US)",
    volume = "16",
    pages = "181--185",
    journal = "High Altitude Medicine and Biology",
    issn = "1527-0297",
    publisher = "Mary Ann Liebert Inc.",
    number = "3",

    }

    TY - JOUR

    T1 - Anticoagulation Considerations for Travel to High Altitude

    AU - Deloughery, Thomas

    PY - 2015/9/1

    Y1 - 2015/9/1

    N2 - DeLoughery, Thomas G. Anticoagulation considerations for travel to high altitude. High Alt Med Biol 16:181-185, 2015.-An increasing percentage of the population are on anticoagulation medicine for clinical reasons ranging from stroke prevention in atrial fibrillation to long term prevention of deep venous thrombosis. In recent years, several new direct oral anticoagulants have entered the market. The key questions that should be kept in mind when approaching a potential traveler on anticoagulation are: 1) why is the patient on anticoagulation? 2) do they need to stay on anticoagulation? 3) what are the choices for their anticoagulation? 4) will there be any drug interactions with medications needed for travel? and 5) how will they monitor their anticoagulation while traveling? Knowing the answers to these questions then can allow for proper counseling and planning for the anticoagulated traveler's trip.

    AB - DeLoughery, Thomas G. Anticoagulation considerations for travel to high altitude. High Alt Med Biol 16:181-185, 2015.-An increasing percentage of the population are on anticoagulation medicine for clinical reasons ranging from stroke prevention in atrial fibrillation to long term prevention of deep venous thrombosis. In recent years, several new direct oral anticoagulants have entered the market. The key questions that should be kept in mind when approaching a potential traveler on anticoagulation are: 1) why is the patient on anticoagulation? 2) do they need to stay on anticoagulation? 3) what are the choices for their anticoagulation? 4) will there be any drug interactions with medications needed for travel? and 5) how will they monitor their anticoagulation while traveling? Knowing the answers to these questions then can allow for proper counseling and planning for the anticoagulated traveler's trip.

    KW - anticoagulation

    KW - apixaban

    KW - dabigatran

    KW - deep venous thrombosis

    KW - edoxaban

    KW - rivaroxaban

    KW - warfarin

    UR - http://www.scopus.com/inward/record.url?scp=84940913378&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84940913378&partnerID=8YFLogxK

    U2 - 10.1089/ham.2015.0058

    DO - 10.1089/ham.2015.0058

    M3 - Article

    C2 - 26186419

    AN - SCOPUS:84940913378

    VL - 16

    SP - 181

    EP - 185

    JO - High Altitude Medicine and Biology

    JF - High Altitude Medicine and Biology

    SN - 1527-0297

    IS - 3

    ER -